Mustang Bio Stock Today

MBIO Stock  USD 0.51  0.04  7.27%   


0 of 100

Very Weak

Odds Of Distress

Over 80

Mustang Bio is selling at 0.51 as of the 13th of April 2024; that is -7.27 percent decrease since the beginning of the trading day. The stock's open price was 0.55. Mustang Bio has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. Equity ratings for Mustang Bio are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 13th of February 2024 and ending today, the 13th of April 2024. Click here to learn more.
Business Domain
Pharmaceuticals, Biotechnology & Life Sciences
IPO Date
22nd of August 2017
Health Care
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. The company was incorporated in 2015 and is headquartered in Worcester, Massachusetts. The company has 9.54 M outstanding shares of which 177.98 K shares are now shorted by private and institutional investors with about 0.54 trading days to cover. More on Mustang Bio

Moving together with Mustang Stock

  0.71VRDN Viridian Therapeutics Financial Report 14th of May 2024 PairCorr

Moving against Mustang Stock

  0.68GLUE Monte Rosa Therapeutics Financial Report 9th of May 2024 PairCorr
  0.58IBIO Ibio IncPairCorr
  0.53LLY Eli Lilly Financial Report 25th of April 2024 PairCorr
  0.43ERAS Erasca Inc Financial Report 20th of May 2024 PairCorr
  0.43MRK Merck Company Sell-off TrendPairCorr

Mustang Stock Highlights

Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Mustang Bio's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Mustang Bio or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
CEO, PresidentManuel MD
Thematic IdeaIT (View all Themes)
Business ConcentrationBiotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, NASDAQ Composite, NASDAQ Health Care, IT, Health Care, Biotechnology, Biotechnology, Healthcare, Computing (View all Sectors)
Average Analyst Recommendation
Analysts covering Mustang Bio report their recommendations after researching Mustang Bio's financial statements, talking to executives and customers, or listening in on Mustang Bio's conference calls. The current trade recommendation is based on an ongoing consensus estimate among financial analysts covering Mustang Bio. The Mustang consensus assessment is calculated by taking the average forecast from all of the analysts covering Mustang Bio.
Financial Strength
Based on the analysis of Mustang Bio's profitability, liquidity, and operating efficiency, Mustang Bio is not in a good financial situation at this time. It has a very high odds of going through financial crisis in May. Financial strength of Mustang Bio is based on its profitability, leverage, liquidity, source of funds, and operating efficiency.
Current ValueLast YearChange From Last Year 10 Year Trend
Total Current Liabilities9.2 M15.4 M
Way Down
Slightly volatile
Non Current Liabilities Total2.1 M2.2 M
Notably Down
Pretty Stable
Total Assets16.9 M17.7 M
Notably Down
Slightly volatile
Total Current Assets10.8 M11.3 M
Notably Down
Slightly volatile
Mustang Bio's financial strength is of vital concern to both outside investors and internal stakeholders. Efficiency and cost control are keys to Mustang Bio's success, along with its ability to generate sufficient cash flow to pay bills, repay debt, and make a consistent year-to-year profit.
Financial leverage usually refers to the use of borrowed funds to amplify returns from an investment. In general, analyzing the relationship between debt to total assets helps investors to understand Mustang Bio's financial leverage. It provides some insight into what part of Mustang Bio's total assets is financed by creditors.
By using current balance sheet information, investors can analyze the liability, assets, and equity on Mustang Bio's books and decide whether to invest or hold. Statistics such as return on equity (ROE), debt to equity (D/E) help investors determine how Mustang Bio deploys its capital and how much of that capital is borrowed.
Mustang Bio cash flow analysis is essential to understand how it generates and spends money over a specific period. It can also help you figure out where your money is going and how much cash you have available at a given moment. The company currently holds 2.5 M in liabilities with Debt to Equity (D/E) ratio of 0.35, which is about average as compared to similar companies. Mustang Bio has a current ratio of 9.76, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Mustang Bio until it has trouble settling it off, either with new capital or with free cash flow. So, Mustang Bio's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Mustang Bio sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Mustang to invest in growth at high rates of return. When we think about Mustang Bio's use of debt, we should always consider it together with cash and equity.


1.39 Million
Mustang Bio (MBIO) is traded on NASDAQ Exchange in USA. It is located in 377 Plantation Street, Worcester, MA, United States, 01605 and employs 80 people. Mustang Bio is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Nano-Cap' category with a current market capitalization of 5.45 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Mustang Bio's market, we take the total number of its shares issued and multiply it by Mustang Bio's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Mustang Bio conducts business under Biotechnology sector and is part of Health Care industry. The entity has 9.54 M outstanding shares of which 177.98 K shares are now shorted by private and institutional investors with about 0.54 trading days to cover. Mustang Bio currently holds about 107.37 M in cash with (49.48 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Check Mustang Bio Probability Of Bankruptcy
Ownership Allocation
Mustang Bio holds a total of 9.54 Million outstanding shares. Mustang Bio holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Remember, it does not matter who owns the company or if the company is currently losing money. If the true value of the company is more than the market pays for it currently, you can still have a good investment opportunity.
Check Mustang Ownership Details

Mustang Stock Price Odds Analysis

Contingent on a normal probability distribution, the odds of Mustang Bio jumping above the current price in 90 days from now is close to 99%. The Mustang Bio probability density function shows the probability of Mustang Bio stock to fall within a particular range of prices over 90 days. Given the investment horizon of 90 days Mustang Bio has a beta of 0.885. This indicates Mustang Bio market returns are highly reactive to returns on the market. As the market goes up or down, Mustang Bio is expected to follow. Additionally, mustang Bio has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the NYSE Composite.
  Odds Below 0.51HorizonTargetOdds Above 0.51
0.13%90 days
Based on a normal probability distribution, the odds of Mustang Bio to move above the current price in 90 days from now is close to 99 (This Mustang Bio probability density function shows the probability of Mustang Stock to fall within a particular range of prices over 90 days) .

Mustang Stock Institutional Holders

Institutional Holdings refers to the ownership stake in Mustang Bio that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Mustang Bio's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Mustang Bio's value.
InstituionRecorded OnShares
Macquarie Group Ltd2023-12-31
Fmr Inc2023-12-31
7.2 K
Tower Research Capital Llc2023-12-31
6.4 K
U.s. Bancorp2023-12-31
Ubs Group Ag2023-12-31
Nbc Securities Inc2023-09-30
Advisor Group Holdings, Inc.2023-12-31
Bank Of America Corp2023-12-31
Wells Fargo & Co2023-12-31
Armistice Capital, Llc2023-12-31
435.8 K
Vanguard Group Inc2023-12-31
179.6 K
View Mustang Bio Diagnostics

Mustang Bio Historical Income Statement

Mustang Bio Income Statement is one of the three primary financial statements used for reporting Mustang's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Mustang Bio revenue and expense. Mustang Bio Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At this time, Mustang Bio's Interest Expense is very stable compared to the past year. As of the 13th of April 2024, Depreciation And Amortization is likely to grow to about 2.3 M, while Selling General Administrative is likely to drop about 9 M. View More Fundamentals

Mustang Stock Against Markets

Picking the right benchmark for Mustang Bio stock is fundamental to making educated investment choices. Many naive investors compare their positions with the S&P 500 or with the Nasdaq. But these benchmarks are not all-inclusive and generally should be used only for large-capitalization equities or stock offerings from large companies. When the price of a selected benchmark declines in a down market, there may be an uptick in Mustang Bio stock price where buyers come in believing the asset is cheap. The opposite is true when the market is bullish; so, accurately picking the benchmark for Mustang Bio is critical whether you are bullish or bearish towards Mustang Bio at a given time. Please also check how Mustang Bio's historical prices are related to one of the top price index indicators.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Mustang Bio without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Performance Analysis Now


Performance Analysis

Check effects of mean-variance optimization against your current asset allocation
All  Next Launch Module

Mustang Bio Corporate Management

Elected by the shareholders, the Mustang Bio's board of directors comprises two types of representatives: Mustang Bio inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Mustang. The board's role is to monitor Mustang Bio's management team and ensure that shareholders' interests are well served. Mustang Bio's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Mustang Bio's outside directors are responsible for providing unbiased perspectives on the board's policies.
Lynn MSVP AffairsProfile
Eliot CPAInterim OfficerProfile
Richard MSHead DevelopmentProfile
Matthew JDVP CounselProfile
Bruce MDSenior DevelopmentProfile
Peter CarneyController OfficerProfile

How to buy Mustang Stock?

Before investing in Mustang Bio, you must ensure you fully understand your financial goals and how diversified (or not) your overall investments are now. Then, after you clearly understand your investment objectives, consider investing in Mustang Bio. To buy Mustang Bio stock, you can follow these steps:
  • Choose a brokerage firm: You need to select a brokerage firm to buy shares of Mustang Bio. Some popular options include Charles Schwab, Fidelity, TD Ameritrade, and Robinhood.
  • Open an account: Once you have chosen a brokerage firm, you will need to open an account. You will be required to provide personal information, such as your name, address, and Social Security number.
  • Fund your account: You will need to deposit funds into your brokerage account to purchase Mustang Bio stock. You can do this by transferring funds from your bank account or other investment accounts.
  • Place your order: Once you have located Mustang Bio stock in your brokerage account, you can place your order to buy it. You will need to specify the number of shares you want to buy and the price you are willing to pay.
  • Monitor your investment: After you have purchased Mustang Bio stock, you should monitor your investment to track its performance and make informed decisions about buying, selling, or holding the stock
It's important to note that investing in stocks, such as Mustang Bio, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember various factors, including economic indicators, change in net worth, political events, company-specific news, and investor sentiment, can influence the stock market. These factors can cause fluctuations in stock prices and lead to market volatility affecting your buy or sell decision. However, volatility can also present opportunities for investors to make gains by buying stocks when prices are low and selling when they are high. It's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. For more information on how to buy Mustang Stock please use our How to Invest in Mustang Bio guide.

Already Invested in Mustang Bio?

The danger of trading Mustang Bio is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Mustang Bio is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Mustang Bio. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Mustang Bio is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Mustang Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mustang Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mustang Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mustang Bio Stock:
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mustang Bio. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
To learn how to invest in Mustang Stock, please use our How to Invest in Mustang Bio guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Mustang Stock analysis

When running Mustang Bio's price analysis, check to measure Mustang Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Mustang Bio is operating at the current time. Most of Mustang Bio's value examination focuses on studying past and present price action to predict the probability of Mustang Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Mustang Bio's price. Additionally, you may evaluate how the addition of Mustang Bio to your portfolios can decrease your overall portfolio volatility.
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Is Mustang Bio's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mustang Bio. If investors know Mustang will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mustang Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
Revenue Per Share
Return On Assets
Return On Equity
The market value of Mustang Bio is measured differently than its book value, which is the value of Mustang that is recorded on the company's balance sheet. Investors also form their own opinion of Mustang Bio's value that differs from its market value or its book value, called intrinsic value, which is Mustang Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mustang Bio's market value can be influenced by many factors that don't directly affect Mustang Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mustang Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mustang Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mustang Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.